OTCMKTS:LCDX Caliber Imaging & Diagnostics (LCDX) Stock Price, News & Analysis $0.0001 0.00 (0.00%) As of 03/28/2025 12:08 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartShort InterestBuy This Stock About Caliber Imaging & Diagnostics Stock (OTCMKTS:LCDX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LCDX alerts:Sign Up Key Stats Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.00▼$0.02Volume100 shsAverage Volume4,192 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCaliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.Read More… Remove Ads Receive LCDX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Caliber Imaging & Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address LCDX Stock News HeadlinesStifel Nicolaus Sticks to Its Buy Rating for Caliber Imaging & Diagnostic (LCDX)February 28, 2025 | markets.businessinsider.comLCDX Caliber Imaging & Diagnostics, Inc.February 27, 2025 | seekingalpha.comThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy shareholder value over time. Even as gold prices rise.March 31, 2025 | Golden Portfolio (Ad)Caliber Imaging & Diagnostic (LCDX) was downgraded to a Sell Rating at Bank of America SecuritiesFebruary 27, 2025 | markets.businessinsider.comCaliber Imaging & Diagnostics IncDecember 30, 2024 | morningstar.comCaliber Imaging & Diagnostics, Inc. (LCDX)February 9, 2024 | nz.finance.yahoo.comCaliber Imaging & Diagnostics Inc.February 1, 2024 | wsj.comCaliber Imaging & Diagnostic (LCDX) Gets a Hold from RBC CapitalSeptember 20, 2023 | markets.businessinsider.comSee More Headlines LCDX Stock Analysis - Frequently Asked Questions How have LCDX shares performed this year? Caliber Imaging & Diagnostics' stock was trading at $0.0001 on January 1st, 2025. Since then, LCDX shares have increased by 0.0% and is now trading at $0.0001. View the best growth stocks for 2025 here. How do I buy shares of Caliber Imaging & Diagnostics? Shares of LCDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Caliber Imaging & Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Caliber Imaging & Diagnostics investors own include Etsy (ETSY), NIO (NIO), J C Penney (JCP), Tesla (TSLA), Costco Wholesale (COST), NVIDIA (NVDA) and Advanced Micro Devices (AMD). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryMedical Equipment Current SymbolOTCMKTS:LCDX CIKN/A Webwww.caliberid.com Phone585-239-9800FaxN/AEmployees28Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (OTCMKTS:LCDX) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Caliber Imaging & Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Caliber Imaging & Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.